LI Haizhi, WANG Dan, LI Te. Systematic Review of Efficacy of Milinone in the Treatment of Persistent Pulmonary Hypertension of the Newborn. [J]. 21(3):324-328(2021)
LI Haizhi, WANG Dan, LI Te. Systematic Review of Efficacy of Milinone in the Treatment of Persistent Pulmonary Hypertension of the Newborn. [J]. 21(3):324-328(2021) DOI: 10.14009/j.issn.1672-2124.2021.03.016.
Systematic Review of Efficacy of Milinone in the Treatment of Persistent Pulmonary Hypertension of the Newborn
摘要
目的:系统评价抗心力衰竭药米力农在临床上新的药物治疗作用
即用于新生儿持续性肺动脉高压(persistent pulmonary hypertension of the newborn
OBJECTIVE: To systematically evaluate the clinical efficacy of milinone as anti-heart failure drug in the treatment of persistent pulmonary hypertension of the newborn( PPHN)
so as to provide reference for the evidence-based medicine and new treatment method.METHODS: PubMed
EMBase
Medline
the Cochrane Library
CNKI
VIP database
Wanfang database and CBM were retrieved to collect the randomized controlled trial( RCT) of milrinone + conventional treatment( study group) vs.conventional treatment( control group) for PPHN.The retrieval time was from the establishment of the database to Oct.2019.The literature were screened
data were extracted and literature quality was evaluated according to the Jadad scale.Total response rate
pulmonary artery systolic pressure( PASP)
arterial partial oxygen pressure( PaO
2
) and oxygenation index( OI) were analyzed by using RevMan 5.3 statistical software.RESULTS: Totally 12 literature were extracted
including 722 children.Meta-analysis showed that the total effective rate( RD = 0.19
95%CI = 0.13-0.24
P
<
0.000 01) and PaO
2
( MD = 10.54
95%CI = 6.89-14.19
P
<
0.000 01) of the study group were significantly higher than those of the control group
and PASP was significantly lower than that of the control group( MD =-10.24
95% CI =-14.07--6.40
P
<
0.000 01)
the differences were statistically significant.There was no significant difference in OI between two groups( MD =-0.83
95% CI =-5.92-4.26
P = 0.75
>
0.05).CONCLUSIONS: The application of anti-heart failure drug milrinone can greatly improve the total clinical treatment efficiency and PaO
2
of children with PPHN
reduce the PASP
and greatly help to improve the quality of life of children.
关键词
米力农新生儿持续性肺动脉高压随机对照试验有效性系统评价
Keywords
MilinonePersistent pulmonary hypertension of the newbornRandomized controlled trialEfficacyMeta-analysis
Meta-Analysis of Efficacy and Safety of Ticagrelor Combined with Rosuvastatin Therapy in the Treatment of Unstable Angina Pectoris
Systematic Review of Efficacy and Safety of Sacubitril Valsartan in the Treatment of Hypertension
Efficacy and Safety of Compound Lactobacillus Acidophilus Combined with Different Antispasmodic Agents in the Treatment of Diarrhea Irritable Bowel Syndrome: A Systematic Review
Systematic Review of Efficacy and Safety of Cefoperazone Sulbactam in Obstetrics and Gynecology Infections
Systematic Review of Efficacy and Safety of Linezolid in the Treatment of Drug-Resistant Tuberculosis
Related Author
LUO Ruixiang
ZHANG Chen
WU Yang
FAN Zongjing
CUI Jie
CHEN Can
LI Xiaoye
TIAN Dan
Related Institution
Dept. of Cardiology, Dongfang Hospital of Beijing University of Traditional Chinese Medicine
School of Clinical Medicine, Beijing University of Traditional Chinese Medicine
North District Branch,Beijing Emergency Medical Center
Dept.of Pharmacy, Zhongshan Hospital, Fudan University
Dept.of Pharmacy, Children’s Hospital Affiliated to Zhengzhou University